Reference no: EM131088987

SITUATION 1:

In 2002, the drugstore chain Walgreens and the pharmaceutical company Eli Lilly were sued after a Florida consumer received an unsolicited free sample of the antidepressant drug Prozac Weekly in the mail. The recipient had kept her depression secret for many years-from her family, friends, and employers-fearing that she would suffer repercussions if her mental condition was known. Imagine her surprise when she received Prozac Weekly in the mail, along with a letter from Walgreens and her doctors. The sample itself was supplied free by the manufacturer, Eli Lilly. She filed a class action suit alleging invasion of privacy, unfair trade practices, and commercial exploitation of confidential medical information by all parties. Is it acceptable for drug makers to market products directly to drugstore customers, using past patient records as indicators of the drugs they might need? Are patients helped by this practice? Are they harmed? What about their rights to privacy? What are the dangers of drug companies being closely aligned with drugstore chains?

Read Situation 3 on page 368 of Ch. 10 in Managing Business Ethics.

Post a 175- to 350-word response to the posed questions at the end of the situation scenario.

• Is it acceptable for drug makers to market products directly to drugstore customers, using past patient records as indicators of the drugs they might need? Are there any legal or ethical ramifications doing so?
• Are patients helped by this practice? Are they harmed?
• What about their rights to privacy?
• What are the dangers of drug companies being closely aligned with drugstore chains? What might be the ethical dilemma created